Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares dip below 20,000 points amid Middle East tensions
04/16/2024 11:44 AM - Business
U.S. dollar up in Taipei trading
04/16/2024 11:28 AM - Society
No injuries reported in Banqiao fire; residents advised to wear masks
04/16/2024 11:08 AM - Politics
Economics minister, NDC chief among new Cabinet members announced
04/16/2024 11:02 AM - Society
Taiwan headline news
04/16/2024 10:24 AM